• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于眼内病变的Occu-Prosta I-125种子源的剂量测定与治疗计划

Dosimetry and treatment planning of Occu-Prosta I-125 seeds for intraocular lesions.

作者信息

Chaudhari Suresh, Deshpande Sudesh, Anand Vivek, De Sandeep, Saxena Sanjay, Dash A, Basu Mahua, Samant Preetam, Kannan V

机构信息

Department of Radiation Oncology, P. D. Hinduja National Hospital and MRC, Mumbai, India.

出版信息

J Med Phys. 2008 Jan;33(1):14-8. doi: 10.4103/0971-6203.39419.

DOI:10.4103/0971-6203.39419
PMID:20041047
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2786092/
Abstract

Intraocular malignant lesions are frequently encountered in clinical practice. Plaque brachytherapy represents an effective means of treatment for intraocular lesions. Recently Radiopharmaceutical Division, BARC, Mumbai, has indigenously fabricated reasonable-cost I-125 sources. Here we are presenting the preliminary experience of dosimetry of sources, configuration of treatment planning system (TPS) and quality assurance (QA) for eye plaque therapy with Occu-Prosta I-125 seeds, treated in our hospital, for a patient with ocular lesions. I-125 seeds were calibrated using well-type chamber. BrachyVision TPS was configured with Monte Carlo computed radial dose functions and anisotropy functions for I-125 sources. Dose calculated by TPS at different points in central axis and off axis was compared with manually calculated dose. Eye plaque was fabricated of 17 karat pure gold, locally. The seeds were arranged in an outer ring near the edge of the plaque and in concentric rings throughout the plaque. The sources were manually digitized on the TPS, and dose distribution was calculated in three dimensions. Measured activity using cross-calibrated well-type chamber was within +/-10% of the activity specified by the supplier. Difference in TPS-calculated dose and manually calculated dose was within 5%. Treatment time calculated by TPS was in concordance with published data for similar plaque arrangement.

摘要

眼内恶性病变在临床实践中经常遇到。斑块近距离放射治疗是治疗眼内病变的一种有效方法。最近,孟买巴巴原子研究中心放射药物分部自主制造了成本合理的碘-125源。在此,我们介绍了我院使用奥克前列腺碘-125籽源对一名眼部病变患者进行眼部斑块治疗时,源剂量测定、治疗计划系统(TPS)配置和质量保证(QA)的初步经验。碘-125籽源使用井型电离室进行校准。使用针对碘-125源的蒙特卡罗计算径向剂量函数和各向异性函数配置了近距离放射治疗视觉TPS。将TPS在中心轴和离轴不同点计算的剂量与手动计算的剂量进行比较。眼部斑块在当地由17克拉纯金制成。籽源排列在斑块边缘附近的外环以及整个斑块的同心环中。在TPS上手动对源进行数字化,并计算三维剂量分布。使用交叉校准的井型电离室测量的活度在供应商规定活度的±10%以内。TPS计算剂量与手动计算剂量的差异在5%以内。TPS计算的治疗时间与类似斑块排列的已发表数据一致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2786092/77b626866a7d/JMP-33-14-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2786092/3bd80d6c0486/JMP-33-14-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2786092/3292570dc8fd/JMP-33-14-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2786092/9f1c9ced00e2/JMP-33-14-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2786092/bed4911ae41d/JMP-33-14-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2786092/77b626866a7d/JMP-33-14-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2786092/3bd80d6c0486/JMP-33-14-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2786092/3292570dc8fd/JMP-33-14-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2786092/9f1c9ced00e2/JMP-33-14-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2786092/bed4911ae41d/JMP-33-14-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2786092/77b626866a7d/JMP-33-14-g005.jpg

相似文献

1
Dosimetry and treatment planning of Occu-Prosta I-125 seeds for intraocular lesions.用于眼内病变的Occu-Prosta I-125种子源的剂量测定与治疗计划
J Med Phys. 2008 Jan;33(1):14-8. doi: 10.4103/0971-6203.39419.
2
Comparison of dose calculation methods for brachytherapy of intraocular tumors.眼内肿瘤近距离放疗中剂量计算方法的比较。
Med Phys. 2011 Jan;38(1):306-16. doi: 10.1118/1.3523614.
3
Validation of American Association of Physicists in Medicine TG 43 Dosimetry Data in Commercial Treatment Planning System.医学物理师协会TG 43剂量测定数据在商用治疗计划系统中的验证
J Med Phys. 2021 Jul-Sep;46(3):197-203. doi: 10.4103/jmp.JMP_20_21. Epub 2021 Sep 8.
4
Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.(125)I 和(103)Pd COMS 眼内肿瘤敷贴器的剂量学:AAPM 和 ABS 的 TG-129 报告。
Med Phys. 2012 Oct;39(10):6161-84. doi: 10.1118/1.4749933.
5
An approach to using conventional brachytherapy software for clinical treatment planning of complex, Monte Carlo-based brachytherapy dose distributions.一种使用传统近距离放射治疗软件进行基于蒙特卡罗的复杂近距离放射治疗剂量分布临床治疗计划的方法。
Med Phys. 2009 Jun;36(6):1968-75. doi: 10.1118/1.3121510.
6
Dosimetric verification of a dedicated 3D treatment planning system for episcleral plaque therapy.用于巩膜外斑块治疗的专用三维治疗计划系统的剂量验证。
Int J Radiat Oncol Biol Phys. 2001 Nov 15;51(4):1159-66. doi: 10.1016/s0360-3016(01)01768-0.
7
A novel quality assurance system for eye plaque brachytherapy.
Australas Phys Eng Sci Med. 2019 Dec;42(4):1109-1115. doi: 10.1007/s13246-019-00808-8. Epub 2019 Nov 14.
8
Episcleral eye plaque dosimetry comparison for the Eye Physics EP917 using Plaque Simulator and Monte Carlo simulation.使用斑块模拟器和蒙特卡罗模拟对Eye Physics EP917巩膜眼斑块剂量测定进行比较
J Appl Clin Med Phys. 2015 Nov 8;16(6):226-239. doi: 10.1120/jacmp.v16i6.5659.
9
Measured, calculated, and egs_brachy I-125 dose distributions in a gold plaque for retinoblastoma treatment.金盘用于视网膜母细胞瘤治疗的测量、计算和 egs_brachy I-125 剂量分布。
Med Phys. 2022 Sep;49(9):6183-6194. doi: 10.1002/mp.15845. Epub 2022 Jul 18.
10
Advanced Collapsed cone Engine dose calculations in tissue media for COMS eye plaques loaded with I-125 seeds.高级塌陷圆锥体引擎在加载 I-125 种子的 COMS 眼斑的组织介质中的剂量计算。
Med Phys. 2018 Jul;45(7):3349-3360. doi: 10.1002/mp.12946. Epub 2018 May 23.

引用本文的文献

1
A Retrospective Study on Using a Novel Single Needle Cone Puncture Approach for the Iodine-125 Seed Brachytherapy in Treating Patients With Thoracic Malignancy.一项关于采用新型单针锥形穿刺方法进行碘-125粒子近距离放射治疗胸部恶性肿瘤患者的回顾性研究。
Front Oncol. 2021 May 31;11:640131. doi: 10.3389/fonc.2021.640131. eCollection 2021.
2
Episcleral plaque brachytherapy using 'BARC I-125 Ocu-Prosta seeds' in the treatment of intraocular tumors: a single-institution experience in India.眼外膜斑块近距离放射治疗联合“BARC I-125 Ocu-Prosta 种子”治疗眼内肿瘤:印度单机构经验。
Indian J Ophthalmol. 2012 Jul;60(4):289-95. doi: 10.4103/0301-4738.98708.

本文引用的文献

1
Improved treatment planning for COMS eye plaques.COMS眼敷贴的治疗计划改进
Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1227-42. doi: 10.1016/j.ijrobp.2004.09.062.
2
The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas.美国近距离放射治疗学会关于葡萄膜黑色素瘤近距离放射治疗的建议。
Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):544-55. doi: 10.1016/s0360-3016(03)00006-3.
3
The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18.
碘125近距离放射治疗脉络膜黑色素瘤的COMS随机试验,III:初始死亡率研究结果。COMS报告第18号。
Arch Ophthalmol. 2001 Jul;119(7):969-82. doi: 10.1001/archopht.119.7.969.
4
Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16.脉络膜黑色素瘤协作研究(COMS)关于¹²⁵I近距离放射治疗中等大小脉络膜黑色素瘤的随机试验。I. 3年后的视力。COMS报告第16号。
Ophthalmology. 2001 Feb;108(2):348-66. doi: 10.1016/s0161-6420(00)00526-1.
5
Well-ionization chamber response relative to NIST air-kerma strength standard for prostate brachytherapy seeds.相对于用于前列腺近距离治疗种子源的美国国家标准与技术研究院空气比释动能强度标准的电离室响应。
Med Phys. 2000 Oct;27(10):2293-6. doi: 10.1118/1.1290715.
6
American Association of Physicists in Medicine Radiation Therapy Committee Task Group 53: quality assurance for clinical radiotherapy treatment planning.美国医学物理师协会放射治疗委员会任务组53:临床放射治疗治疗计划的质量保证
Med Phys. 1998 Oct;25(10):1773-829. doi: 10.1118/1.598373.
7
Code of practice for brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group No. 56. American Association of Physicists in Medicine.近距离放射治疗物理学实践指南:美国医学物理学家协会放射治疗委员会第56任务组报告
Med Phys. 1997 Oct;24(10):1557-98. doi: 10.1118/1.597966.
8
Brachytherapy in primary ocular tumors.原发性眼肿瘤的近距离放射治疗。
Semin Surg Oncol. 1997 May-Jun;13(3):167-76. doi: 10.1002/(sici)1098-2388(199705/06)13:3<167::aid-ssu3>3.0.co;2-5.
9
125I eye plaque dose distribution including penumbra characteristics.
Med Phys. 1996 Mar;23(3):407-18. doi: 10.1118/1.597803.
10
Dosimetry for 125I seed (model 6711) in eye plaques.用于眼部敷贴器中125I粒子(6711型)的剂量测定。
Med Phys. 1993 Mar-Apr;20(2 Pt 1):383-9. doi: 10.1118/1.597164.